J J Jobsen

Summary

Publications

  1. pmc Timing of radiotherapy in breast-conserving therapy: a large prospective cohort study of node-negative breast cancer patients without adjuvant systemic therapy
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Br J Cancer 108:820-5. 2013
  2. doi request reprint Sequence of radiotherapy and chemotherapy in breast cancer after breast-conserving surgery
    Jan J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Int J Radiat Oncol Biol Phys 82:e811-7. 2012
  3. doi request reprint The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor
    Jan J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Gynecol Oncol 117:32-6. 2010
  4. doi request reprint The impact of margin status in breast-conserving therapy for lobular carcinoma is age related
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Eur J Surg Oncol 36:176-81. 2010
  5. ncbi request reprint Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma
    C L Creutzberg
    Department of Radiation Oncology, University Hospital Rotterdam Daniel den Hoed Cancer Center, The Netherlands
    Lancet 355:1404-11. 2000
  6. ncbi request reprint Multicenter cohort study on treatment results and risk factors in stage II endometrial carcinoma
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Int J Gynecol Cancer 18:1071-8. 2008
  7. ncbi request reprint The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands
    Eur J Cancer 37:1820-7. 2001
  8. doi request reprint Use of primary radiotherapy for rectal cancer in the Netherlands between 1997 and 2008: a population-based study
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Clin Oncol (R Coll Radiol) 24:e1-8. 2012
  9. ncbi request reprint Treatment results in women with clinical stage I and pathologic stage II endometrial carcinoma
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Int J Gynecol Cancer 11:49-53. 2001
  10. doi request reprint Mapping use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997 and 2008
    C C E Koning
    Department of Radiation Oncology, Academic Medical Centre, University of Amsterdam, The Netherlands
    Clin Oncol (R Coll Radiol) 24:e46-53. 2012

Collaborators

Detail Information

Publications15

  1. pmc Timing of radiotherapy in breast-conserving therapy: a large prospective cohort study of node-negative breast cancer patients without adjuvant systemic therapy
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Br J Cancer 108:820-5. 2013
    ..To investigate the issue of timing of radiation therapy (RT) after lumpectomy in relation to recurrences and outcome...
  2. doi request reprint Sequence of radiotherapy and chemotherapy in breast cancer after breast-conserving surgery
    Jan J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Int J Radiat Oncol Biol Phys 82:e811-7. 2012
    ..The optimal sequence of radiotherapy and chemotherapy in breast-conserving therapy is unknown...
  3. doi request reprint The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor
    Jan J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Gynecol Oncol 117:32-6. 2010
    ..The aim of this study was to look at the impact of the number of sites with tumour involvement on outcome for patients with stage IIIA endometrioid-type endometrial carcinoma...
  4. doi request reprint The impact of margin status in breast-conserving therapy for lobular carcinoma is age related
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Eur J Surg Oncol 36:176-81. 2010
    ..The aim is to look at the impact of margin status and outcome of invasive lobular carcinoma (ILC) treated with breast-conserving therapy (BCT)...
  5. ncbi request reprint Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma
    C L Creutzberg
    Department of Radiation Oncology, University Hospital Rotterdam Daniel den Hoed Cancer Center, The Netherlands
    Lancet 355:1404-11. 2000
    ..We did a multicentre prospective randomised trial to find whether postoperative pelvic radiotherapy improves locoregional control and survival for patients with stage-1 endometrial carcinoma...
  6. ncbi request reprint Multicenter cohort study on treatment results and risk factors in stage II endometrial carcinoma
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Int J Gynecol Cancer 18:1071-8. 2008
    ..5 also showed to be significant for DMFS and DFS. Our study showed grade 3 to be the most important single independent predictive factor for locoregional and distant recurrences in endometrial carcinoma stage II...
  7. ncbi request reprint The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands
    Eur J Cancer 37:1820-7. 2001
    ..Taking into account results from a subset analysis suggests that giving systemic therapy to a subgroup of women who are < or =40 years, node-negative and/or have a positive family history might give a better local control...
  8. doi request reprint Use of primary radiotherapy for rectal cancer in the Netherlands between 1997 and 2008: a population-based study
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Clin Oncol (R Coll Radiol) 24:e1-8. 2012
    ..To describe variation in the utilisation rates of primary radiotherapy for patients with rectal cancer in the Netherlands, focusing on time trends and age effects...
  9. ncbi request reprint Treatment results in women with clinical stage I and pathologic stage II endometrial carcinoma
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands
    Int J Gynecol Cancer 11:49-53. 2001
    ..The present treatment policy seems justified, except for patients with pathologic stage IIB and grade 3, in which a more aggressive treatment should be considered...
  10. doi request reprint Mapping use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997 and 2008
    C C E Koning
    Department of Radiation Oncology, Academic Medical Centre, University of Amsterdam, The Netherlands
    Clin Oncol (R Coll Radiol) 24:e46-53. 2012
    ....
  11. ncbi request reprint Synchronous, bilateral breast cancer: prognostic value and incidence
    J J Jobsen
    Department of Radiation Oncology, Medisch Spectrum Twente Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands
    Breast 12:83-8. 2003
    ..As the LRR is similar for BBC and UBC, BCT is not contraindicated in BBC. The incidence of BBC is low, at 1.5% which makes it difficult to reach any more definitive conclusions on outcome and treatment...
  12. doi request reprint Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors
    C C E Koning
    Department of Radiation Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
    Ann Oncol 23:2948-53. 2012
    ..Several French, Belgian and Dutch radiation oncologists have reported good results with the combination of limited surgery after external beam radiotherapy (EBRT) followed by brachytherapy in early-stage muscle-invasive bladder cancer...
  13. ncbi request reprint Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990-2001
    S Siesling
    Comprehensive Cancer Centre Stedendriehoek Twente, Hoedemakerplein 2, 7511 JP, Enschede, The Netherlands
    Breast 16:606-14. 2007
    ..Cancer registry data are useful to monitor the guideline implementation strategies. Multidisciplinary treatment planning, surgeon and patient education could increase the use of BCS combined with RT in all age groups...
  14. doi request reprint A population-based study on the utilisation rate of primary radiotherapy for prostate cancer in 4 regions in the Netherlands, 1997-2008
    P M P Poortmans
    Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands
    Radiother Oncol 99:207-13. 2011
    ..The purpose was to study variations in utilisation rates of external beam radiotherapy (EBRT) and brachytherapy (BT) for prostate cancer patients...
  15. ncbi request reprint The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial
    C L Creutzberg
    Department of Radiation Oncology, University Hospital Rotterdam Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Int J Radiat Oncol Biol Phys 51:1246-55. 2001
    ..To compare the treatment complications for patients with Stage I endometrial cancer treated with surgery and pelvic radiotherapy (RT) or surgery alone in a multicenter randomized trial...